Renal Outcome in Patients With COVID-19
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 40
Summary
- Conditions
- Acute Kidney Injury
- Corona Virus Infection
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Beginning in December 2019, a novel coronavirus, designated as severe acute respiratory distress coronavirus 2 (SARS-CoV-2), has caused an international outbreak of respiratory illness termed coronavirus disease 2019 (COVID-19). Although the clinical manifestations of COVID-19 are dominated by respi...
Beginning in December 2019, a novel coronavirus, designated as severe acute respiratory distress coronavirus 2 (SARS-CoV-2), has caused an international outbreak of respiratory illness termed coronavirus disease 2019 (COVID-19). Although the clinical manifestations of COVID-19 are dominated by respiratory symptoms, some patients show severe kidney abnormalities. Acute kidney injury (AKI) is reported to occur in 0.5-9% of SARS-CoV-2 positive patients and AKI has been identified as an independent risk factor for in-hospital mortality. The present study aims to investigate the incidence of of renal outcome of in-hospital patients diagnosed with COVID-19.
Tracking Information
- NCT #
- NCT04353583
- Collaborators
- Not Provided
- Investigators
- Study Director: Werner Seeger, MD University Hospital Giessen and Marburg, Giessen